The latest immunotherapy news and developments
Immunotherapies that activate T cells to eliminate cancer cells have shown limited efficacy as standalone…
Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide…
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research,…
Organ transplant recipients with advanced cancer, an often overlooked group in cancer care, may benefit…
Results from the DIAmOND clinical trial have shown that adding dual immunotherapy to existing treatments…
A new research paper was published in Volume 16 of Oncotarget on May 19, 2025, titled “Immune-mediated adverse…
A new review was published in Volume 16 of Oncotarget on May 19, 2025, titled “Advancements in bladder…
Nivolumab in combination with ipilimumab has been granted an indication extension in the UK by…
Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with the Instituto de…
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with over 70% of…